These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31630275)

  • 81. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: a United States multicentre study.
    Gawrieh S; Dakhoul L; Miller E; Scanga A; deLemos A; Kettler C; Burney H; Liu H; Abu-Sbeih H; Chalasani N; Wattacheril J
    Aliment Pharmacol Ther; 2019 Oct; 50(7):809-821. PubMed ID: 31475372
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan.
    Kusakabe A; Tanaka Y; Orito E; Sugauchi F; Kurbanov F; Sakamoto T; Shinkai N; Hirashima N; Hasegawa I; Ohno T; Ueda R; Mizokami M
    J Gastroenterol; 2007 Apr; 42(4):298-305. PubMed ID: 17464459
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays.
    Kuper HE; Tzonou A; Kaklamani E; Hadziyannis S; Tasopoulos N; Lagiou P; Trichopoulos D; Stuver S
    Cancer Causes Control; 2000 Feb; 11(2):171-5. PubMed ID: 10710202
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence.
    Donato F; Gelatti U; Limina RM; Fattovich G
    Oncogene; 2006 Jun; 25(27):3756-70. PubMed ID: 16799617
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis.
    Chiesa R; Donato F; Tagger A; Favret M; Ribero ML; Nardi G; Gelatti U; Bucella E; Tomasi E; Portolani N; Bonetti M; Bettini L; Pelizzari G; Salmi A; Savio A; Garatti M; Callea F
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):213-6. PubMed ID: 10698484
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y; Tani M; Kurata T; Abe K
    Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).
    Trinchet JC; Bourcier V; Chaffaut C; Ait Ahmed M; Allam S; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Buffet C; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Thiefin G; Hillaire S; Di Martino V; Nahon P; Chevret S;
    Hepatology; 2015 Sep; 62(3):737-50. PubMed ID: 25678021
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Next big threat for Pakistan Hepatocellular Carcinoma (HCC).
    Parkash O; Hamid S
    J Pak Med Assoc; 2016 Jun; 66(6):735-9. PubMed ID: 27339578
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Clinical and aetiological profile of hepatoma at a tertiary care centre.
    Joshi N; Kumar A; Rani MS; Chandra N; Ramanjaneyulu ER
    Trop Gastroenterol; 2003; 24(2):73-5. PubMed ID: 14603825
    [TBL] [Abstract][Full Text] [Related]  

  • 93. HCV and HBV coexist in HBsAg-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area.
    Lee DS; Huh K; Lee EH; Lee DH; Hong KS; Sung YC
    J Gastroenterol Hepatol; 1997 Dec; 12(12):855-61. PubMed ID: 9504897
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies.
    Petrick JL; Florio AA; Koshiol J; Pfeiffer RM; Yang B; Yu K; Chen CJ; Yang HI; Lee MH; McGlynn KA
    Int J Cancer; 2020 Nov; 147(10):2743-2753. PubMed ID: 32406072
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.
    Nakano M; Yatsuhashi H; Bekki S; Takami Y; Tanaka Y; Yoshimaru Y; Honda K; Komorizono Y; Harada M; Shibata M; Sakisaka S; Shakado S; Nagata K; Yoshizumi T; Itoh S; Sohda T; Oeda S; Nakao K; Sasaki R; Yamashita T; Ido A; Mawatari S; Nakamuta M; Aratake Y; Matsumoto S; Maeshiro T; Goto T; Torimura T
    Sci Rep; 2022 Jan; 12(1):1517. PubMed ID: 35087153
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures.
    Tanaka M; Katayama F; Kato H; Tanaka H; Wang J; Qiao YL; Inoue M
    J Epidemiol; 2011; 21(6):401-16. PubMed ID: 22041528
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A Systematic Review of the Current Hepatitis B Viral Infection and Hepatocellular Carcinoma Situation in Mediterranean Countries.
    Madihi S; Syed H; Lazar F; Zyad A; Benani A
    Biomed Res Int; 2020; 2020():7027169. PubMed ID: 32626758
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Association between hepatitis B and E virus infection and hepatocellular carcinoma risk.
    Xue M; Lin X; Lin QX; Pu X; Liu J; Li XF; Hou J; Liu X; Chen R
    Int J Cancer; 2021 Jun; 148(12):2974-2981. PubMed ID: 33554326
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
    Shiels MS; Engels EA; Yanik EL; McGlynn KA; Pfeiffer RM; O'Brien TR
    Cancer; 2019 Aug; 125(15):2621-2630. PubMed ID: 30980394
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
    Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
    Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.